gyro, both of the two new directors are associated with Trinity Diagnostics.
My guess is that Moro has been in contact Trinity Diagnostics in some manner. Trinity may be one of the companies that was interested in RECAF in 2008.
To have Wittenberg gone and add these two certainly is a positive step.
Unfortunately, that still does not change my mind on the long term acceptance of RECAF by the medical community. RECAF has a long hard road ahead and I wish Moro luck.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.